Skip to main content

The first FDA approved non-mask therapy designed to treat CSA 

The remedē® System is an implantable system that safely and effectively treats moderate to severe central sleep apnea (CSA) in adult patients.1

RESTORES a more normal breathing pattern by using the body’s own breathing system.

TAILORS therapy to each patient through customized programming that attempts to mimic natural breathing while asleep.

RELIEVES patient compliance concerns by automatically delivering therapy each night.

ELIMINATES external equipment using a mask-free, implantable device that is placed under the skin int he upper chest area during a minimally invasive, outpatient procedure.

See how the remedē System is implanted

The Latest Advancement in remedē® System Technology

The remedē EL-X System is a next generation platform combining enhanced functionality with a patient-friendly design that simplifies the implant procedure and delivers long-lasting benefits to your adult patients with central sleep apnea.

Next Generation Platform

Extended longevity

Long-lasting battery life extended by 40% from previous platform1

Patient-friendly design

Small and thin; size decreased by 25% from previous model1 with rounded edges designed for comfort

Simplified Implant

Single lead, single port system

Delivers stimulation and senses respiration from a single lead, simplifying the implant experience

Next Generation remedē Reports

Enhanced with DRēAM View

remedē Reports software is designed to deliver insightful information for you to efficiently tailor therapy for your patients. The latest enhancement, DRēAM View, provides an enhanced set of full-night, detailed data detected by the device.

remedē EL System

Built on the same next-generation platform, the remedē EL is designed for compatibility with current IS-1 leads.